Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis

Singh, Shweta; Adam, Mohamed; Matkar, Pratiek N.; Bugyei-Twum, Antoinette; Desjardins, Jean-Francois; Chen, Hao H.; Nguyen, Hien; Bazinet, Hannah; Michels, David; Liu, Zongyi; Mebrahtu, Elizabeth; Esene, Lillian; Joseph, Jameela; Ehsan, Mehroz; Qadura, Mohammad; Connelly, Kim A.; Leong-Poi, Howard; Singh, Krishna K.

doi:10.1038/s41598-020-61292-9

Download PDF

Article
Open access
Published: 11 March 2020

Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis

Shweta Singh¹,
Mohamed Adam^3,5,
Pratiek N. Matkar^3,5,
Antoinette Bugyei-Twum^3,5,
Jean-Francois Desjardins³,
Hao H. Chen^3,5,
Hien Nguyen^2,8,
Hannah Bazinet²,
David Michels²,
Zongyi Liu²,
Elizabeth Mebrahtu²,
Lillian Esene²,
Jameela Joseph^2,9,
Mehroz Ehsan²,
Mohammad Qadura^4,5,
Kim A. Connelly^3,5,
Howard Leong-Poi^3,5 &
…
Krishna K. Singh^2,4,5,6,7,8

Scientific Reports volume 10, Article number: 4466 (2020) Cite this article

3415 Accesses
19 Citations
2 Altmetric
Metrics details

Subjects

Abstract

Intraflagellar transport protein 88 (Ift88) is required for ciliogenesis and shear stress-induced dissolution of cilia in embryonic endothelial cells coincides with endothelial-to-mesenchymal transition (EndMT) in the developing heart. EndMT is also suggested to underlie heart and lung fibrosis, however, the mechanism linking endothelial Ift88, its effect on EndMT and organ fibrosis remains mainly unexplored. We silenced Ift88 in endothelial cells (ECs) in vitro and generated endothelial cell-specific Ift88-knockout mice (Ift88^endo) in vivo to evaluate EndMT and its contribution towards organ fibrosis, respectively. Ift88-silencing in ECs led to mesenchymal cells-like changes in endothelial cells. The expression level of the endothelial markers (CD31, Tie-2 and VE-cadherin) were significantly reduced with a concomitant increase in the expression level of mesenchymal markers (αSMA, N-Cadherin and FSP-1) in Ift88-silenced ECs. Increased EndMT was associated with increased expression of profibrotic Collagen I expression and increased proliferation in Ift88-silenced ECs. Loss of Ift88 in ECs was further associated with increased expression of Sonic Hedgehog signaling effectors. In vivo, endothelial cells isolated from the heart and lung of Ift88^endo mice demonstrated loss of Ift88 expression in the endothelium. The Ift88^endo mice were born in expected Mendelian ratios without any adverse cardiac phenotypes at baseline. Cardiac and pulmonary endothelial cells isolated from the Ift88^endo mice demonstrated signs of EndMT and bleomycin treatment exacerbated pulmonary fibrosis in Ift88^endo mice. Pressure overload stress in the form of aortic banding did not reveal a significant difference in cardiac fibrosis between Ift88^endo mice and control mice. Our findings demonstrate a novel association between endothelial cilia with EndMT and cell proliferation and also show that loss of endothelial cilia-associated increase in EndMT contributes specifically towards pulmonary fibrosis.

Fibroblast and myofibroblast activation in normal tissue repair and fibrosis

Article 08 April 2024

Stem cell-based therapy for human diseases

Article Open access 06 August 2022

Cells of the adult human heart

Article Open access 24 September 2020

Introduction

Primary cilia (singular: cilium) are short (1–3 μm) hair-like projections arising from the surface of almost every vertebrate cell. Cilia are not completely bound by the plasma membrane but they represent a spatially distinct compartment separated from the rest of the cell¹. Cilia depend upon an evolutionarily conserved mechanism of a microtubule-based transport system called intraflagellar transport (IFT) for its maintenance and function². Deletion of intraflagellar transport 88 (Ift88) results in loss of cilia³. Endothelial cells (ECs) line the heart and blood vessels and, as a result, are constantly exposed to hemodynamic forces. The endothelium is very sensitive to fluctuations in these dynamic physical and chemical conditions and, under physiological conditions, responds accordingly by releasing autocrine and paracrine factors⁴. The differential EC response to constantly varying flow patterns requires accurate mechanotransduction and mechanosensing⁴. In adult vasculature, primary cilia are located at atherosclerotic-prone sites where the flow is oscillatory and slow⁵, and recently a protective role of endothelial cilia was demonstrated where the loss of endothelial cilia promoted endothelial dysfunction and atherosclerosis in ApoE^null mice⁶. It is important to note that physiologically endothelial cilia is not a permanent structure and embryonic ECs which are exposed to high shear stress, temporarily dissolve their cilia and this process coincides with transforming growth factor-β (Tgfβ)-induced endothelial-to-mesenchymal transition (EndMT)⁷. High shear stress associated dissolution of cilia and EndMT occurs during the formation the primordia of cardiac valves during heart development⁷. EndMT is marked by fibroblast-like morphology, induction of Tgfβ signaling, loss of EC markers like CD31, VE-Cadherin and Tie-2, and gain of mesenchymal markers like alpha-smooth muscle actin (αSMA) and N-Cadherin^8,9.

Although EndMT is well-established as a crucial process in heart development, it has now been implicated in a variety of pathologies including organ fibrosis and cancer^4,8. The etiologic factors initiating fibrotic disorders are diverse and in most cases remain obscure, however, the accumulation of activated myofibroblasts remains a vital determinant of the severity and rate of disease progression and their response to therapy, prognosis as well as to mortality¹⁰. Previous observations that EndMT may also contribute to the generation of pro-fibrotic cells both in vitro¹¹ as well as in vivo¹², multiple immunofluorescence and EC-lineage-tracing studies conducted during the developmental course of various animal models of tissue fibrosis have demonstrated that EndMT is a significant source of tissue myofibroblasts¹³. EndMT, as a critical step in pulmonary fibrosis, was elegantly demonstrated by Hashimoto et al., who exploited lineage analysis to trace the source of interstitial fibroblasts in a bleomycin-induced lung fibrosis and reported that approximately 16% of lung fibroblasts were of endothelial origin^10,14,15. These studies were validated by lineage-tracing and the results subsequently confirmed by other laboratories^4,10. Cardiac fibrosis also results from an excessive extracellular matrix deposition mediated by the recruitment of fibroblasts from various sources^16,17,18. Nonetheless, the origin of these fibroblasts is not completely understood¹⁹. Traditionally, adult fibroblasts directly originate from embryonic mesenchymal cells and increase in number due to the proliferation of resident fibroblasts^17,19. Although controversial, albeit different stages, EndMT has been implicated in cardiac fibrosis, in addition to the proliferation of resident fibroblasts^20,21. However, in the setting of loss of endothelial cilia, the contribution of EndMT towards fibroblasts accumulation, and cardiac and pulmonary fibrosis remains unknown. Furthermore, endothelial dysfunction predicts future cardiovascular morbidity²². While endothelial-cardiomyocyte crosstalk is influential in cardiac physiology/pathology^23,24, the role of endothelial cilia in the cardiac remodeling caused by increased EndMT, either in development or pathogenesis, remains unclear.

The overarching goal of this study is to determine whether permanent loss of endothelial cilia induces EndMT and whether loss of cilia-associated increased EndMT exacerbates the progression of cardiac and pulmonary fibrosis. We hypothesize that an intact ciliary machinery plays an essential role in limiting EndMT and that loss of endothelial cilia results in impaired endothelial function and increased cardiac and pulmonary fibrosis. Our data demonstrate that loss of endothelial Ift88 leads to EndMT and increased proliferation in vitro, and exacerbates bleomycin-induced pulmonary fibrosis in vivo. Our data also indicates that loss of endothelial cilia associated EndMT does not contribute towards pressure-overload induced cardiac fibrosis, supporting studies where EndMT was demonstrated not to participate in cardiac fibrosis¹⁸.

Results

Loss of Ift88 induced marked morphological and ultrastructural changes, EndMT, increased proliferation and migration in ECs in vitro

We used siRNA technology to knock down Ift88 expression in HUVECs. The cells were divided into three groups: 1. non-transfected, 2. scrambled control-transfected, and 3. siIft88-transfected ECs. The non-transfected cells were indistinguishable from the scrambled control-transfected cells therefore results from the non-transfected group is not presented. Silencing of Ift88 was optimized using three different doses (1, 5 and 10 nM) of siIft88. Quantitative PCR (qPCR) and immunoblot analysis confirmed successful silencing as evident by reduced Ift88 expression at the transcript (Fig. 1A) and protein levels (Fig. 1B) in ECs transfected with 5 nM of siIft88 24, 48, and 72 hours post-transfection. Particularly, Ift88-silenced ECs demonstrated transition from the distinctive cobblestone-like morphology to an enlarged spindle-shaped fibroblast-like appearance indicative of EndMT in the siIft88-silenced ECs (Fig. 1C). Next, to evaluate EndMT, we examined the expression levels of endothelial (CD31, Tie-2 and VE-Cadherin) and mesenchymal [α-smooth muscle actin (αSMA), N-Cadherin and Fibroblast-specific Protein 1 (FSP1)] markers at the transcript and protein levels in scrambled control- and siIft88-transfected ECs. Our EndMT marker analysis data demonstrated a significant reduction in the expression level of endothelial markers CD31, Tie-2 and VE-Cadherin with a concomitant increase in the expression level of mesenchymal markers αSMA, N-Cadherin and FSP-1 at both the transcript (Fig. 1D) and protein (Fig. 1E) levels in the siIft88-transfected in comparison to scrambled control-transfected HUVECs.

Furthermore, to confirm that loss of Ift88-associated EndMT is not specific to HUVECs we silenced Ift88 in HCAECs and HPAECs and evaluated the phenotype. We were successfully able to silence Ift88 in HCAECs at the transcript (Fig. 2A) and at the protein level (Fig. 2B). The siIft88-silenced and scrambled control-transfected endothelial cells were immunostained with antibodies for Ift88 and also for acetylated-tubulin to observe the cilia. Loss of Ift88 caused the loss of cilia in siIft88-transfected HCAECs (Fig. 2C). We also observed the loss of cobblestone-like morphology and gain of enlarged spindle-shaped pattern in the HCAECs (Fig. 2D). These changes were accompanied by an elevation in expression and organized arrangements for mesenchymal cell-like cytoskeletal protein α-actinin (Fig. 2E). Next, to evaluate EndMT, we examined the expression levels of endothelial (CD31, Tie-2 and VE-Cadherin) and mesenchymal (αSMA, N-Cadherin and FSP1) markers at the transcript and protein levels in scrambled control- and siIft88-transfected HCAECs. Our EndMT marker analysis data demonstrated a significant reduction in the expression level of endothelial markers CD31, Tie-2 and VE-Cadherin with a concomitant significant increase in the expression level of mesenchymal markers αSMA, N-Cadherin and FSP-1 at both transcript (Fig. 3A) and protein (Fig. 3B) levels in the siIft88-transfected in comparison to scrambled control-transfected HCAECs. EndMT was also confirmed by immunofluorescence for Ift88, VE-Cadherin and αSMA in siIft88- and scrambled control-transfected HCAECs. Immunofluorescence data further confirmed EndMT with reduced CD31 and VE-Cadherin and increased αSMA expression in the Ift88-silenced in comparison to the scrambled control-transfected HCAECs (Fig. 3C). In humans, endothelial cells undergoing EndMT demonstrate higher proliferation and migration^25,26. To determine if the loss of Ift88-associated EndMT is also associated with increased proliferation and migration, we evaluated proliferation in scramble control- and siIft88-transfected HCAECs. In line with previous findings, our data demonstrated an increased proliferation in the Ift88-silenced in comparison to the scrambled-control transfected HCAECs (Fig. 3D). Similar to HCAECs, we were also able to silence Ift88 at the transcript and the protein level in HPAECs (Fig. 4A,B). Loss of Ift88 in HPAECs led to EndMT switching at the transcript and the protein level (Fig. 4C,D), as well as increased proliferation and migration (Fig. 4E,F). Overall, our data demonstrate that loss of endothelial cilia-associated EndMT and increased proliferation is not specific to an endothelial cell type.

Ift88 Loss does not activate TGFβ and Wnt/β-catenin signaling but Up-regulates sonic hedgehog (Shh) signaling in ECs in vitro

TGFβ-signaling is the main inducer of EndMT²⁷. Cilia regulates sonic hedgehog (shh) and Wnt/β-Catenin signaling^28,29,30. Wnt/β-Catenin interacts with Tgfβ-signaling, and loss of cilia is associated with an increased translocation of β-Catenin to the nucleus that is also known to participate in the induction of EndMT³¹. Therefore, we evaluated the effect of loss of Ift88 or cilia on these three Tgfβ-, Wnt/β-Catenin- and Shh-signaling in ECs. To our surprise, we did not observe any significant changes in the expression level of ligand Tgfβ1, receptors TGFBR1 and TGFBR2 and effectors such as Smad2 of Tgfβ-signaling and Tgfβ-target gene CTGF in the Ift88-silenced ECs, when compared with scrambled control-transfected ECs (Fig. 5A,B; Suppl. Fig. 1A,B). Similar data were obtained across HCAEC (Fig. 5A,B), HUVEC (Suppl. Fig. 1A) and HPAECs (data not shown). Additionally, we also measured the expression levels of Tgfβ1, TGFBR1 and TGFBR2 in the MLECs isolated from WT and Ift88^endo mice and did not observe any significant difference between the groups (Suppl. Fig. 1C–E). Next, we treated scrambled control and siIft88-tranfected ECs with human recombinant Tgfβ1 and measured the expression level of EndMT markers and Ift88. Our data show a clear induction of EndMT and reduction in Ift88 in the control ECs but Tgfβ1-treatment had no additive effect on the EndMT marker expression in the Ift88-silenced ECs (Suppl. Fig. 2A,B). Moreover, we also did not observe any significant changes in the expression level of β-Catenin in the siIft88-silenced in comparison to scrambled control-transfected ECs. Given that β-Catenin translocates to the nucleus for its activity, we measured the translocation of β-Catenin from the cytoplasm to the nucleus, which appears not to be affected by the loss of Ift88 in ECs (Fig. 5C). Lastly, Shh is known to be regulated by cilia and loss of cilia is associated with reduced Shh signaling³². However, we observed that the receptor for PTC that plays an obligate negative regulatory role in the Shh-signaling pathway was unaffected, but the mediators of Shh-signaling, such as SMO and zinc-finger transcription factor GL1, were significantly up-regulated in the Ift88-silenced ECs (Fig. 5D).

Endothelial cell-specific loss of Ift88-associated increase in EndMT does not exacerbate pressure overload-induced cardiac fibrosis in vivo

In order to extend our in vitro findings to an in vivo setting, endothelial cell-specific Ift88 knockout (Ift88^endo) mice were generated using Cre-LoxP technology and were characterized (Fig. 6A). Successful deletion of Ift88 specifically in the cardiac ECs (CECs) was performed by isolating CECs, where CECs from the Ift88^endo mice revealed a virtual absence of Ift88 protein in comparison to CECs from WT control littermates (Fig. 6B). These Ift88^endo mice were born in the expected Mendelian ratios, exhibited no obvious cardiovascular phenotypes or changes in blood pressure, and displayed similar cardiac structure and function in accordance with a previous publication⁶. A histomorphometric assessment was performed on in situ fixed and H&E-stained hearts. Similar baseline cardiac morphologies and structures were found in Ift88^endo mice and their WT littermate controls (Fig. 6C,D). There were no differences in the left ventricular inner (2.31 ± 0.42 mm vs 2.42 ± 0.92 mm, WT vs Ift88^endo, p = n.s.) and outer (3.87 ± 0.85 mm vs 3.91 ± 0.77 mm, WT vs Ift88^endo, p = n.s) diameter, septal wall thickness (1.04 ± 0.13 mm vs 0.99 ± 0.26 mm, WT vs Ift88^endo, p = n.s), and average cross sectional area of cardiomyocytes between the groups (Fig. 6C,D). Echocardiographic measurements demonstrated an indistinguishable cardiac function between Ift88^endo mice and their WT littermate controls at 8–12 weeks of age (Table 1). The transverse aortic constriction (TAC) model is a widely employed model to study pressure overload-induced cardiac fibrosis and heart failure. Accordingly, we induced TAC in the Ift88^endo mice and the WT control littermates and measured cardiac function and fibrosis 6-weeks after TAC. To our surprise, our data demonstrated that endothelial-specific loss of Ift88 did not exacerbate cardiac dysfunction as measured by echocardiography (Fig. 6E,F) and fibrosis as measured by staining for collagen deposition between Ift88^endo mice and the WT control littermates (Fig. 6G).

Table 1 Echocardiographic assessments demonstrate a similar cardiac function at baseline between control and Ift88^endo mice.

Full size table

Endothelial cell-specific loss of Ift88 induces EndMT and exacerbates bleomycin (BLM)-induced pulmonary fibrosis in vivo

To further confirm the successful deletion of Ift88, we isolated RNA and protein from the lung tissues of the wild-type, endothelial cell-specific Ift88 heterozygous knockout mice (Ift88^het) and Ift88^endo mice and measured Ift88 expression. The Ift88 transcript and Ift88 protein analysis demonstrated reduced expression of Ift88 in the lung (Fig. 7A,B). To evaluate the deletion of Ift88 specifically in the mouse lung endothelial cells (MLECs), MLECs were isolated from the WT and IFT88^endo mice and Ift88 was measured. Ift88 transcript and the protein data confirmed a complete absence of Ift88 in the Ift88^endo MLECs at the protein levels (Fig. 7C). Next, to validate the loss of Ift88-associated EndMT in HPAECs in the MLECs isolated from the Ift88^endo, all the EndMT markers were evaluated. The transcript data performed for the endothelial markers demonstrated a significant reduction (Fig. 7D), as observed in the Ift88-silenced ECs. To evaluate the potential translational implications of our in vitro data, bleomycin (BLM) was instilled in the lungs of the wild-type and Ift88^endo mice and lung fibrosis was evaluated. BLM induces variable pulmonary fibrosis based on the strain and genetic background of the mice, however, WT and IFT88^end mice utilized in the current study were of mixed background and BLM is shown to induce pulmonary fibrosis in these mice^33,34,35. We observed profound alterations in the pulmonary microanatomy of BLM-treated Ift88^endo when compared with similarly treated wild-type mice. These differences included increased alveolar septal thickening and infiltration of the parenchyma by inflammatory cells with a resultant increase in pulmonary fibrosis and collagen content 21 days after BLM instillation in the Ift88^endo mice (Fig. 7E). These data were further confirmed by evaluating the Ashcroft score, which also demonstrated BLM-induced exacerbated pulmonary fibrosis in Ift88^endo in comparison to WT mice (Fig. 7F).

Discussion

Organ fibrosis represents the final common pathway through which various ischemic, hemodynamic, inflammatory, and genotoxic risk factors lead to organ failure. Amongst the several mechanisms that have been suggested to underlie organ fibrosis, increasing data points toward a critical and previously underappreciated role of endothelial-to-mesenchymal transition (EndMT) as a source of fibroblasts. These data have generated considerable translational enthusiasm since they imply that molecular and/or cellular targeting of EndMT may serve to limit aberrant fibroblastic flux and, through this mechanism, reduce the genesis of organs, such as cardiac and pulmonary fibrosis. Our overall aim was to evaluate novel mechanisms governing EndMT, EndMT-mediated aberrant remodeling and organ fibrosis. Specifically, we hypothesized that endothelial primary cilia play a critical role in the process of EndMT, and that loss of endothelial primary cilial assembly is a fundamental step through which endothelial cells acquire a pathologic mesenchymal phenotype that in turn culminates in cardiac and pulmonary fibrosis, and organ failure. We investigated this hypothesis by: (i) silencing the cilial assembly gene Intraflagellar transport 88 (Ift88) in the endothelial cells and then by evaluating EndMT, and (ii) by conducting comprehensive studies in mice that have the essential ciliary assembly gene conditionally knocked out in endothelial cells.

Successful Ift88 knockdown via RNA silencing (siRNA) in ECs led to the loss of cilia (Figs. 1A,B and 2A–C). Our studies further indicated that loss of cilia promoted EndMT and was accompanied by marked morphological and ultrastructural changes whereby ECs transitioned from the typical “cobblestone-like” morphology to an enlarged spindle-shaped, smooth surfaced “fibroblast-like” morphology (Figs. 1C and 2D). Notably, at the subcellular level, Ift88-silenced ECs exhibited cytoskeletal protein re-organization as confirmed by α-actinin staining (Fig. 2E). At the molecular level, disruption of Ift88 expression was associated with reduced expression of the EC markers CD31, Tie-2 and VE-Cadherin, and increased expression of the mesenchymal markers αSMA, N-Cadherin and fibroblast-specific protein (FSP1) (Figs. 1D,E, 3A–C and 4C,D). Changes observed with loss of Ift88 in HUVECs were mirrored in Human Coronary Artery ECs (HCAECs) and Human Pulmonary Artery ECs (HPAECs) (Figs. 1–4).

Deletion of Ift88 results in the loss of cilia³. Cilia amplify the cytoskeletal strain and regulate endothelial function³⁶. Furthermore, the endocardial cushions in the embryonic heart, which are exposed to high shear stress, are marked by the temporary dissolution of cilia in embryonic ECs³⁷. These ECs with dissolved cilia undergo Tgfβ-driven EndMT⁷. EndMT is thought to be initiated by inductive signals like Tgfβs and β-Catenin from the myocardium^{7,38,39,40,41}. Although EndMT is crucial in heart development, it has also been implicated in a wide variety of pathologies namely cancer and organ fibrosis^4,8,33. A recent study demonstrates that loss of endothelial cilia promotes endothelial dysfunction and atherosclerosis in ApoE^null mice⁴². Given that EndMT can be defined as a gain of mesenchymal cell function, but at the same time, it can also be looked as a loss of endothelial function. Therefore, loss of endothelial cilia-associated increased atherosclerosis in ApoE^null mice might have been due to EndMT-mediated loss of endothelial function. Cilia mainly regulate sonic hedgehog (Shh) and Wnt/β-Catenin signaling^28,29,30, where Wnt/β-Catenin interacts with Tgfβ-signaling, and loss of cilia are associated with increased translocation of β-Catenin to the nucleus that induces EndMT³¹. The dissolution of primary cilia is known to induce Tgfβ signaling and EndMT in mice embryonic endothelial cells⁴³. The Shh-signaling pathway is known to play an important role during the developmental process⁴⁴, however, Shh-signaling is not known to be associated with the process of EndMT. Therefore, we postulated that EC-specific loss of Ift88 or cilia may result in aberrant Wnt/β-Catenin and Tgfβ signaling, leading to increased EndMT in adult human endothelial cells. To our surprise, the ligand for Tgfβ-signaling Tgfβ1, Tgfβ receptors; TGFBR1 and TGFBR2, and the effectors: Smad2 and pSmad2 were not significantly affected in Ift88-silenced ECs (Fig. 5A,B). To further confirm that loss of Ift88/cilia associated effect on Tgfβ-signaling is not HCAECs-specific, we measured the expression of TGFBR1, TGFBR2, Smad2 and pSMad2 in Ift88-silenced HUVECs and observed similar results, as these Tgfβ-signaling associated molecules were also not affected in Ift88-silenced HUVECs (Suppl. Fig. 1A,B). We then measured the expression level of Tgfβ1, TGFBR1 and TGFBR2 in the MLECs isolated from adult WT and Ift88^endo mice, which also did not show any significant change in these molecules (Suppl. Fig. 1C–E). All of these evaluated Tgfβ-related molecules appear to be non-significant in Ift88-deficient ECs in comparison to control ECs, indicating that loss of endothelial cilia associated activation of Tgfβ-signaling is differentially regulated in mice embryonic endothelial cells versus adult endothelial cells, potentially due to higher plasticity of embryonic endothelial cells. To evaluate any possible correlation between Ift88 and Tgfβ-signaling in adult human ECs, we then treated control and Ift88-silenced ECs with recombinant human Tgfβ1 and measured the extent of EndMT marker expression and the expression level of Ift88. Tgfβ1-treatment significantly induced EndMT in scrambled control-transfected ECs, as previously reported^33,45, but interestingly, had no additive effect on the extent of EndMT in the Ift88-silenced ECs (Suppl. Fig. 2A). Tgfβ1-induced EndMT coincided with reduced expression of Ift88, indicating an inverse relationship between EndMT and Ift88/cilia in response to Tgfβ1 (Suppl. Fig. 2B). We also did not observe any significant change in the expression or activity of β-Catenin in the Ift88-silenced ECs as expected in comparison to controls (Fig. 5C). Therefore, we looked at the effect of loss of Ift88 on Shh-signaling and evaluated the expression level of PTC, SMO, and GL1. We observed a significantly up-regulated SMO and GL1 in the Ift88-silenced in comparison to scrambled control-transfected ECs (Fig. 5D). This is a novel finding as Shh-signaling is not known to be associated with EndMT. However, further studies are currently underway to understand the contribution of the upregulation of SMO and GL1 in relation to loss of Ift88/cilia in ECs, and also the association, if any, of Shh signaling with EndMT.

Cardiac fibrosis is mediated by the recruitment of fibroblasts, and accordingly, there has been an immense interest to gain a better understanding of the molecular underpinnings through which fibroblasts accumulate since they may offer clues for potential translational evaluation and treatment of heart failure. Although the source of fibroblasts in cardiac fibrosis is controversial, it is expected to be multifactorial. Recent data indicate that cardiac fibrosis is associated with the emergence of fibroblasts originating from ECs and that EndMT, an event that occurs during the formation of the atrioventricular cushion in the embryonic heart, may also play an important, albeit pathological role, in the post-natal state^18,19. Furthermore, increased mesenchymal cell proliferation and migration is associated with EndMT and tissue fibrosis^25,46. Transforming growth factor-β1 (Tgfβ1) induces ECs to undergo EndMT, whereas Bone Morphogenetic Protein 7 (BMP-7), which preserves the endothelial phenotype, significantly inhibits EndMT and the progression of cardiac fibrosis in mouse models of pressure overload¹⁹. Primary cilia are cellular protrusions that serve as mechanosensors for fluid flow and also render ECs prone to shear-induced EndMT in embryonic endothelial cells of mice⁴³. Therefore, we hypothesized that an intact ciliary machinery plays a fundamental role in limiting aberrant EndMT and that loss of endothelial cilial assembly unleashes EndMT, exacerbating cardiac fibrosis. Accordingly, and also to extend our in vitro findings to an in vivo setting, endothelial cell-specific Ift88 knockout (Ift88^endo) mice were generated using Cre-LoxP technology and were characterized (Fig. 6A–D). These mice were born in expected Mendelian ratios, exhibited no obvious cardiovascular phenotypes or changes in blood pressure, and displayed similar cardiac structure and function (Fig. 6C,D) in accordance with a previous publication⁶. Despite normal endothelial and vascular architecture, CECs from these mice exhibited reduced expression levels of CD31 and VE-Cadherin. Interestingly, in spite of these differences, structurally and functionally, the hearts of Ift88^endo mice were indistinguishable from those of their wild-type littermate controls under baseline conditions. Furthermore, to understand the implication of our in vitro findings and also to delineate the contribution of EndMT towards cardiac fibrosis, we used the transverse aortic constriction (TAC) model, which is a widely employed animal model to study cardiac fibrosis. Although we observed the signs of EndMT in the cardiac ECs, the extent of cardiac fibrosis was not different between the Ift88^endo and the control littermates (Fig. 6G). Similarly, we did not observe any difference in the cardiac functions when measured post-TAC via echocardiography (Fig. 6E, F). Our data indicate that the loss of endothelial cilia-associated EndMT is not a significant source of fibroblast exacerbating cardiac fibrosis in Ift88^endo mice after TAC, which supports a previous finding that the cardiac resident fibroblasts but not the EndMT-related fibroblasts contribute to the genesis of pressure overload-associated cardiac fibrosis^18,19.

EndMT is elegantly demonstrated as a critical step in the progression of pulmonary fibrosis by lineage-tracing the source of interstitial fibroblasts in bleomycin-induced lung fibrosis, and approximately 16% of lung fibroblasts were found to be of endothelial origin^10,14,15. We isolated MLECs from the lungs of Ift88^endo and the wild-type control littermates. We then confirmed the successful deletion of Ift88 and EndMT-like switching as all the endothelial markers were significantly reduced (Fig. 7C,D). Given the confirmed contribution of EndMT in the exacerbation of bleomycin-induced EndMT, we hypothesized that loss of endothelial cilia-associated increase in EndMT will exacerbate bleomycin-induced pulmonary fibrosis. To understand, the role of loss of endothelial cilia-associated EndMT in the progression of bleomycin-induced pulmonary fibrosis, we instilled bleomycin to the lungs of Ift88^endo and the wild-type control littermates. Upon instilling bleomycin into the lungs, we observed increased alveolar septal thickening, infiltration of the parenchyma by inflammatory cells, and increase in bronchocentric collagen content in the fibrotic lungs of Ift88^endo mice in comparison to the wild-type control littermates (Fig. 7E). BLM-induced exacerbated pulmonary fibrosis in Ift88^endo in comparison to WT mice was also confirmed by an increased Ashcroft score in the lung sections of BLM-treated ft88^endo mice (Fig. 7F). These results indicate that loss of endothelial cilia-associated increase in EndMT in the lungs of Ift88^endo mice exacerbated pulmonary fibrosis, which supports our hypothesis. Next, we aim to delineate the exact contribution of cilia-associated EndMT towards exacerbated pulmonary fibrosis utilizing the lineage-tracing technique. However, a major determinant of negative prognosis in pulmonary fibrosis is the degree of new reactive fibroblasts recruited to the lungs, thus therapeutic methods targeting the sources of fibroblasts are effective approaches in order to improve the fibrotic condition and its complication. Our current study presents novel findings of the mechanism through which lung endothelial cells could possibly contribute to pulmonary fibrosis. We demonstrated in vitro and in vivo that lungs endothelial cells undergoing EndMT could serve to be a critical source of fibroblasts and an inducer of EndMT is the loss of endothelial primary cilia. Future studies are, thus, warranted to investigate approaches to prevent the loss of endothelial cilia-associated EndMT or EndMT per se and the related signaling mechanisms in the development of pulmonary fibrosis.

Materials and Methods

Cell culture and Ift88 silencing

Human Umbilical Vein ECs (HUVECs, Lonza), Human Coronary Artery ECs (HCAECs, Lonza) and Human Pulmonary Artery ECs (HPAECs, Lonza) were grown in EC growth medium-2 (EGM™-2 Bulletkit™; Lonza) containing growth factors or MCDB 131 (Gibco) supplemented with serum and antibiotics. siRNA-mediated Ift88 gene knockdown studies were performed with 5 nM siIft88 or scrambled control (Ambion) and the Dharmafect-4 transfection reagent (Dharmacon) in accordance with the manufacturer’s instructions. Following 60–70% confluence, cells were starved overnight and then treated with 10 ng TGFβ1 (Santa Cruz Biotechnology) and the control groups were treated with the diluent. Cardiac primary endothelial cells were isolated using the protocol as described⁴⁷.

Proliferation and migration assay

HCAECs were seeded at a density of 1–1.5×10⁴ cells/well in 96-well plates, transfected with siIft88 or scrambled control. Cell proliferation was evaluated 24 hrs post-transfection using WST-8 Cell Proliferation Assay Kit (Cayman Chemicals) according to the manufacturer’s guidelines. Following 24 hrs of transfection with either siIft88 or scrambled control, HPAECs were re-seeded in a density of 2×10⁵ cells/well in the upper chamber of the Cyto-Select 24-well Cell Migration Fluorometric Assay system (Cell Biolabs, Inc). Cell migration was evaluated after 12-hrs of incubation according to the manufacturer’s instruction.

Quantitative real-time PCR

Total RNA was extracted using Trizol® as instructed (Invitrogen). Complementary DNA (cDNA) was synthesized using the Quantitect kit (Qiagen). Quantitative polymerase chain reaction (qPCR) was performed using the ABI ViiA 7 Real-Time PCR System (Applied Biosystems). For the PCR reaction, SYBR® Select Master Mix or TaqMan® Gene Expression Assays (both Applied Biosystems) were mixed with forward and reverse primers for Ift88, CD31, VE-Cadherin, Tie-2, αSMA, N-Cadherin, fibroblast-specific protein-1 (FSP1), Connective Tissue Growth factor (CTGF), TGFβ1, Patched (PTC; Forward – 5′-CTC-ATA-TTT-GGG-GCC-TTC-G-3′; Reverse – 5′-TCT-CCA-ATC-TTC-TGG-CGA-GT-3′), smoothened protein (SMO; Forward – 5′-GG-CTC-CCA-GGA-GGA-AGC-3′; Reverse – 5′-GGT-CAT-TCT-CAC-ACT-TGG-GC-3′), Glioma-associated oncogene homolog (GL1; Forward – 5′-CCA-GCG-CCC-AGA-CAG-AG-3′; Reverse – 5′-GGC-TCG-CCA-TAG-CTA-CTG-AT-3′) and GAPDH according to the manufacturer’s recommendations and as described previously^33,48,49.

Immunoblot, immunofluorescence and immunohistochemistry

Transfected ECs were harvested 24, 48 and 72 hour post-transfection with either siIft88 or scrambled control. Total cell lysates were prepared in RIPA buffer (Sigma Aldrich) and protein was extracted and quantified. An Equal amount of proteins were loaded on sodium dodecyl sulfate (SDS) polyacrylamide gels for immunoblotting analysis. The primary antibodies were utilized at a dilution of 1:1000: Ift88 (Santa Cruz Biotechnology #84318), CD31 (Cell Signaling #3528), VE-Cadherin (Santa Cruz Biotechnology #6458), Tie2 (Santa Cruz Biotechnology #324), N-Cadherin (abcam #ab76057), FSP1 (Abnova #H00006275-M01), αSMA (abcam #ab5694), α-actinin (Cell Signaling #3134), TGFβ1 (abcam #ab9758), SMAD2 (Cell Signaling #3122), pSMAD2 (Cell Signaling #3101), β-catenin (Cell Signaling #8480), phospho-β-catenin (Cell Signaling #9561), and GAPDH (Millipore #MAB374). The blot was developed using an enhanced chemiluminescence substrate (SuperSignal^TM, Life Technologies) and a ChemiDoc^TM imaging system (Bio-Rad). Densitometry (ImageJ software) was performed to quantify the band intensities. Immunofluorescence experiments were carried out in 4-chamber microscopy slides performed as previously described^33,48,49. Immunofluorescence signals from Acetyl-tubulin, CD31, VE-Cadherin, αSMA, Ift88 and α-actinin staining were visualized with standard protocols 24 hours post-treatment. Fluorescent microscopy images were captured using the Zeiss LSM700 confocal microscope and ZEN imaging software was utilized for image processing. Hearts and lung tissues were perfused, harvested, and cleared of extraneous tissue before being fixed in O.C.T. compound (Tissue-Tek®) for cryosectioning. Sections were stained with hematoxylin and eosin (H&E) or Masson’s trichrome. The severity of pulmonary fibrosis was quantified by Ashcroft scoring system⁵⁰.

Generation of endothelial cell-specific Ift88 knock-out mice and aortic banding

EC-specific Ift88 knock-out (Ift88^endo) mice were generated via crossing floxed Ift88 mice (Ift88^flox/flox mice) with VE-cadherin Cre transgenic mice^6,33. Generation and the characterization of EC-specific Ift88 knock-out mice has been described previously⁶. A single dose of BLM (0.0015 units/g body weight, Sigma) was instilled endotracheally on day 0- to 20-week-old mice⁵¹. All animal-related experiments and procedures were reviewed and approved by the St. Michael’s Hospital Animal Care Committee, and all methods were performed in accordance with the relevant guidelines and regulations.

Statistical analysis

Student’s T-test was utilized to compare the means of two groups. Differences between multiple means were calculated by analysis of variance, and when overall differences were detected, individual means were compared post-hoc with the Bonferroni’s test. A p-value <0.05 was accepted as statistical significance. Data are expressed as the mean ± SD.

References

Gherman, A., Davis, E. E. & Katsanis, N. The ciliary proteome database: an integrated community resource for the genetic and functional dissection of cilia. Nat. Genet. 38, 961–962, https://doi.org/10.1038/ng0906-961 (2006).
Article CAS PubMed Google Scholar
Scholey, J. M. Kinesin-2 motors transport IFT-particles, dyneins and tubulin subunits to the tips of Caenorhabditis elegans sensory cilia: relevance to vision research? Vis. Res. 75, 44–52, https://doi.org/10.1016/j.visres.2012.06.015 (2012).
Article CAS PubMed Google Scholar
Wann, A. K. et al. Primary cilia mediate mechanotransduction through control of ATP-induced Ca2+ signaling in compressed chondrocytes. FASEB journal: Off. Publ. Federation Am. Societies Exp. Biol. 26, 1663–1671, https://doi.org/10.1096/fj.11-193649 (2012).
Article CAS Google Scholar
Vita, J. A. Endothelial function. Circulation 124, e906–912, https://doi.org/10.1161/CIRCULATIONAHA.111.078824 (2011).
Article PubMed Google Scholar
Van der Heiden, K. et al. Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis. Atherosclerosis 196, 542–550, https://doi.org/10.1016/j.atherosclerosis.2007.05.030 (2008).
Article CAS PubMed Google Scholar
Dinsmore, C. & Reiter, J. F. Endothelial primary cilia inhibit atherosclerosis. EMBO Rep. 17, 156–166, https://doi.org/10.15252/embr.201541019 (2016).
Article CAS PubMed PubMed Central Google Scholar
Nakajima, Y., Yamagishi, T., Hokari, S. & Nakamura, H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec 258, 119–127, doi:10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U (2000).
Goumans, M. J., van Zonneveld, A. J. & ten Dijke, P. Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends cardiovascular Med. 18, 293–298, https://doi.org/10.1016/j.tcm.2009.01.001 (2008).
Article CAS Google Scholar
Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. investigation 119, 1429–1437, https://doi.org/10.1172/JCI36183 (2009).
Article CAS Google Scholar
Flammer, A. J. & Luscher, T. F. Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases. Swiss Med. Wkly. 140, w13122, https://doi.org/10.4414/smw.2010.13122 (2010).
Article PubMed Google Scholar
Arciniegas, E., Sutton, A. B., Allen, T. D. & Schor, A. M. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J. Cell Sci. 103(Pt 2), 521–529 (1992).
CAS PubMed Google Scholar
O’Riordan, E. et al. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. American journal of physiology. Heart circulatory Physiol. 292, H285–294, https://doi.org/10.1152/ajpheart.00560.2006 (2007).
Article CAS Google Scholar
Lee, S. W. et al. Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis. Mol. therapy: J. Am. Soc. Gene Ther. 21, 1767–1777, https://doi.org/10.1038/mt.2013.146 (2013).
Article CAS Google Scholar
Hashimoto, N. et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. respiratory Cell Mol. Biol. 43, 161–172, https://doi.org/10.1165/rcmb.2009-0031OC (2010).
Article CAS Google Scholar
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrology: JASN 19, 2282–2287, https://doi.org/10.1681/ASN.2008050513 (2008).
Article Google Scholar
Piera-Velazquez, S., Li, Z. & Jimenez, S. A. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am. J. Pathol. 179, 1074–1080, https://doi.org/10.1016/j.ajpath.2011.06.001 (2011).
Article CAS PubMed PubMed Central Google Scholar
Krenning, G., Zeisberg, E. M. & Kalluri, R. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 225, 631–637, https://doi.org/10.1002/jcp.22322 (2010).
Article CAS PubMed PubMed Central Google Scholar
Moore-Morris, T. et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 124, 2921–2934, https://doi.org/10.1172/JCI74783 (2014).
Article CAS PubMed PubMed Central Google Scholar
Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952–961, https://doi.org/10.1038/nm1613 (2007).
Article CAS Google Scholar
Rivera-Feliciano, J. et al. Development of heart valves requires Gata4 expression in endothelial-derived cells. Dev. 133, 3607–3618, https://doi.org/10.1242/dev.02519 (2006).
Article CAS Google Scholar
Zhou, B., von Gise, A., Ma, Q., Hu, Y. W. & Pu, W. T. Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Developmental Biol. 338, 251–261, https://doi.org/10.1016/j.ydbio.2009.12.007 (2010).
Article CAS Google Scholar
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. & Munzel, T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673–2678 (2001).
Article CAS Google Scholar
Brutsaert, D. L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiological Rev. 83, 59–115, https://doi.org/10.1152/physrev.00017.2002 (2003).
Article CAS Google Scholar
MacCarthy, P. A. et al. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation 104, 2967–2974 (2001).
Article CAS Google Scholar
Tang, H. et al. Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am. J. Physiol. Lung Cell Mol. Physiol 314, L256–L275, https://doi.org/10.1152/ajplung.00096.2017 (2018).
Article CAS PubMed Google Scholar
Stenmark, K. R., Frid, M. & Perros, F. Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH. Circulation 133, 1734–1737, https://doi.org/10.1161/CIRCULATIONAHA.116.022479 (2016).
Article PubMed PubMed Central Google Scholar
Cooley, B. C. et al. TGF-beta signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci. Transl. Med. 6, 227ra234, https://doi.org/10.1126/scitranslmed.3006927 (2014).
Article CAS Google Scholar
Haycraft, C. J. et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet. 1, e53, https://doi.org/10.1371/journal.pgen.0010053 (2005).
Article CAS PubMed PubMed Central Google Scholar
Vaillant, C. & Monard, D. SHH pathway and cerebellar development. Cerebellum 8, 291–301, https://doi.org/10.1007/s12311-009-0094-8 (2009).
Article PubMed Google Scholar
Corbit, K. C. et al. Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms. Nat. Cell Biol. 10, 70–76, https://doi.org/10.1038/ncb1670 (2008).
Article CAS PubMed Google Scholar
Cheon, S. S., Nadesan, P., Poon, R. & Alman, B. A. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp. Cell Res. 293, 267–274 (2004).
Article CAS Google Scholar
Bangs, F. & Anderson, K. V. Primary Cilia and Mammalian Hedgehog Signaling. Cold Spring Harb Perspect Biol 9, https://doi.org/10.1101/cshperspect.a028175 (2017).
Article Google Scholar
Singh, K. K. et al. The essential autophagy gene ATG7 modulates organ fibrosis via regulation of endothelial-to-mesenchymal transition. J. Biol. Chem. 290, 2547–2559, https://doi.org/10.1074/jbc.M114.604603 (2015).
Article CAS PubMed Google Scholar
Haston, C. K., Amos, C. I., King, T. M. & Travis, E. L. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res. 56, 2596–2601 (1996).
CAS PubMed Google Scholar
Walkin, L. et al. The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair. 6, 18, https://doi.org/10.1186/1755-1536-6-18 (2013).
Article CAS PubMed PubMed Central Google Scholar
Dekker, R. J. et al. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 107, 4354–4363, https://doi.org/10.1182/blood-2005-08-3465 (2006).
Article CAS PubMed Google Scholar
Groenendijk, B. C., der Heiden, V., Hierck, K. & Poelmann, B. P. R. E. The role of shear stress on ET-1, KLF2, and NOS-3 expression in the developing cardiovascular system of chicken embryos in a venous ligation model. Physiol. 22, 380–389, https://doi.org/10.1152/physiol.00023.2007 (2007).
Article CAS Google Scholar
Liebner, S. et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 183, 409–417, https://doi.org/10.1083/jcb.200806024 (2008).
Article CAS PubMed PubMed Central Google Scholar
Camenisch, T. D. et al. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Developmental Biol. 248, 170–181 (2002).
Article CAS Google Scholar
Lijnen, P. J., Petrov, V. V. & Fagard, R. H. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol. Genet. Metab. 71, 418–435, https://doi.org/10.1006/mgme.2000.3032 (2000).
Article CAS PubMed Google Scholar
Ramsdell, A. F. et al. Identification of an autocrine signaling pathway that amplifies induction of endocardial cushion tissue in the avian heart. Acta anatomica 162, 1–15 (1998).
Article CAS Google Scholar
Dinsmore, C. & Reiter, J. F. Endothelial primary cilia inhibit atherosclerosis. EMBO Rep. https://doi.org/10.15252/embr.201541019 (2016).
Article PubMed PubMed Central Google Scholar
Egorova, A. D. et al. Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition. Circ. Res. 108, 1093–1101, https://doi.org/10.1161/CIRCRESAHA.110.231860 (2011).
Article CAS PubMed PubMed Central Google Scholar
Ingham, P. W., Nakano, Y. & Seger, C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat. Rev. Genet. 12, 393–406, https://doi.org/10.1038/nrg2984 (2011).
Article CAS PubMed Google Scholar
Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M. C. & Ten Dijke, P. TGF-beta-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci 18, https://doi.org/10.3390/ijms18102157 (2017).
Article Google Scholar
Marriott, S. et al. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. Am. J. Physiol. Cell Physiol 307, C684–698, https://doi.org/10.1152/ajpcell.00114.2014 (2014).
Article CAS PubMed PubMed Central Google Scholar
Jelonek, K. et al. Cardiac endothelial cells isolated from mouse heart - a novel model for radiobiology. Acta Biochim. Pol. 58, 397–404 (2011).
Article CAS Google Scholar
Murugavel, S. et al. Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching. Front. Pharmacol. 9, 737, https://doi.org/10.3389/fphar.2018.00737 (2018).
Article CAS PubMed PubMed Central Google Scholar
Matkar, P. N. et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget 7, 69489–69506, https://doi.org/10.18632/oncotarget.11060 (2016).
Article PubMed PubMed Central Google Scholar
Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467–470, https://doi.org/10.1136/jcp.41.4.467 (1988).
Article CAS PubMed PubMed Central Google Scholar
Schrier, D. J., Kunkel, R. G. & Phan, S. H. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127, 63–66, https://doi.org/10.1164/arrd.1983.127.1.63 (1983).
Article CAS PubMed Google Scholar

Download references

Acknowledgements

Funding for this project was provided by grant-in-aid from the Heart and Stroke Foundation of Canada (G-17-0018688) to KKS. KKS is also the recipient of the 2018/19 National New Investigator Award- Salary Support from the Heart and Stroke Foundation of Canada, Canada. The author thanks Dr. Subodh Verma and Dr. Mohammed Al-Omran for their support to complete the study.

Author information

Authors and Affiliations

Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON, N6A 5C1, Canada
Shweta Singh
Department of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A 5C1, Canada
Hien Nguyen, Hannah Bazinet, David Michels, Zongyi Liu, Elizabeth Mebrahtu, Lillian Esene, Jameela Joseph, Mehroz Ehsan & Krishna K. Singh
Division of Cardiology, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, ON, M5B 1W8, Canada
Mohamed Adam, Pratiek N. Matkar, Antoinette Bugyei-Twum, Jean-Francois Desjardins, Hao H. Chen, Kim A. Connelly & Howard Leong-Poi
Vascular Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, ON, M5B 1W8, Canada
Mohammad Qadura & Krishna K. Singh
Institute of Medical Science, University of Toronto, Toronto, ON, M5S 1A1, Canada
Mohamed Adam, Pratiek N. Matkar, Antoinette Bugyei-Twum, Hao H. Chen, Mohammad Qadura, Kim A. Connelly, Howard Leong-Poi & Krishna K. Singh
Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A1, Canada
Krishna K. Singh
Departments of Surgery, University of Toronto, Toronto, ON, M5S 1A1, Canada
Krishna K. Singh
Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A 5C1, Canada
Hien Nguyen & Krishna K. Singh
Department of Biology, University of Western Ontario, London, ON, N6A 5C1, Canada
Jameela Joseph

Authors

Shweta Singh
View author publications
You can also search for this author in PubMed Google Scholar
Mohamed Adam
View author publications
You can also search for this author in PubMed Google Scholar
Pratiek N. Matkar
View author publications
You can also search for this author in PubMed Google Scholar
Antoinette Bugyei-Twum
View author publications
You can also search for this author in PubMed Google Scholar
Jean-Francois Desjardins
View author publications
You can also search for this author in PubMed Google Scholar
Hao H. Chen
View author publications
You can also search for this author in PubMed Google Scholar
Hien Nguyen
View author publications
You can also search for this author in PubMed Google Scholar
Hannah Bazinet
View author publications
You can also search for this author in PubMed Google Scholar
David Michels
View author publications
You can also search for this author in PubMed Google Scholar
Zongyi Liu
View author publications
You can also search for this author in PubMed Google Scholar
Elizabeth Mebrahtu
View author publications
You can also search for this author in PubMed Google Scholar
Lillian Esene
View author publications
You can also search for this author in PubMed Google Scholar
Jameela Joseph
View author publications
You can also search for this author in PubMed Google Scholar
Mehroz Ehsan
View author publications
You can also search for this author in PubMed Google Scholar
Mohammad Qadura
View author publications
You can also search for this author in PubMed Google Scholar
Kim A. Connelly
View author publications
You can also search for this author in PubMed Google Scholar
Howard Leong-Poi
View author publications
You can also search for this author in PubMed Google Scholar
Krishna K. Singh
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

K.K.S. conceived and designed the study. P.N.M., A.B., M.A., J.-F. D., H.H.C., H.B., H.N. and M.E. carried out the experiments and analyzed the data. H.L.P., M.Q. and K.A.C. helped write and improve the discussion. S.S., K.K.S., D.M., E.M., Z.L., L.E. and J.J. wrote and assembled the manuscript with final figures and revision.

Corresponding author

Correspondence to Krishna K. Singh.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Figures.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Singh, S., Adam, M., Matkar, P.N. et al. Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. Sci Rep 10, 4466 (2020). https://doi.org/10.1038/s41598-020-61292-9

Download citation

Received: 08 July 2019
Accepted: 19 February 2020
Published: 11 March 2020
DOI: https://doi.org/10.1038/s41598-020-61292-9

This article is cited by

Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E(nd)MT and monocyte infiltration
- Weiming Zhao
- Lan Wang
- Guoying Yu
Cell Communication and Signaling (2023)
Exosomal miR-218 derived from mesenchymal stem cells inhibits endothelial-to-mesenchymal transition by epigenetically modulating of BMP2 in pulmonary fibrosis
- Yuhao Zhao
- Lei Du
- Zhen Li
Cell Biology and Toxicology (2023)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.